Literature DB >> 8497274

Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation.

A T Tikhonenko1, A R Hartman, M L Linial.   

Abstract

The cellular proto-oncogene c-myc can acquire transforming potential by a number of different means, including retroviral transduction. The transduced allele generally contains point mutations relative to c-myc and is overexpressed in infected cells, usually as a v-Gag-Myc fusion protein. Upon synthesis, v-Gag-Myc enters the nucleus, forms complexes with its heterodimeric partner Max, and in this complex binds to DNA in a sequence-specific manner. To delineate the role for each of these events in fibroblast transformation, we introduced several mutations into the myc gene of the avian retrovirus MC29. We observed that Gag-Myc with a mutated nuclear localization signal is confined predominantly in the cytoplasm and only about 5% of the protein could be detected in the nucleus (less than the amount of endogenous c-Myc). Consequently, only a small fraction of Max is associated with Myc. However, cells infected with this mutant exhibit a completely transformed phenotype in vitro, suggesting that production of enough v-Gag-Myc to tie up all cellular Max is not needed for transformation. While the nuclear localization signal is dispensable for transformation, minimal changes in the v-Gag-Myc DNA-binding domain completely abolish its transforming potential, consistent with a role of Myc as a transcriptional regulator. One of its potential targets might be the endogenous c-myc, which is repressed in wild-type MC29-infected cells. Our experiments with MC29 mutants demonstrate that c-myc down-regulation depends on the integrity of the v-Myc DNA-binding domain and occurs at the RNA level. Hence, it is conceivable that v-Gag-Myc, either directly or circuitously, regulates c-myc transcription.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497274      PMCID: PMC359831          DOI: 10.1128/mcb.13.6.3623-3631.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Max and c-Myc/Max DNA-binding activities in cell extracts.

Authors:  T D Littlewood; B Amati; H Land; G I Evan
Journal:  Oncogene       Date:  1992-09       Impact factor: 9.867

2.  A small deletion in the carboxy terminus of the viral myc gene renders the virus MC29 partially transformation defective in avian fibroblasts.

Authors:  P J Enrietto
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

3.  Identification of the human c-myc protein nuclear translocation signal.

Authors:  C V Dang; W M Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

4.  The transforming activity of the chicken c-myc gene can be potentiated by mutations.

Authors:  L Frykberg; T Graf; B Vennström
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

Review 5.  Oncogenes in retroviruses and cells: biochemistry and molecular genetics.

Authors:  K Bister; H W Jansen
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

6.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

7.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

8.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

Authors:  W H Landschulz; P F Johnson; S L McKnight
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

9.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

10.  Definition of regions in human c-myc that are involved in transformation and nuclear localization.

Authors:  J Stone; T de Lange; G Ramsay; E Jakobovits; J M Bishop; H Varmus; W Lee
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

View more
  6 in total

1.  Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA.

Authors:  A Janz; C Sevignani; K Kenyon; C V Ngo; A Thomas-Tikhonenko
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

2.  Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.

Authors:  W J Bowers; L A Baglia; A Ruddel
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.

Authors:  C Grandori; J Mac; F Siëbelt; D E Ayer; R N Eisenman
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

4.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

Authors:  B Lutterbach; S R Hann
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus.

Authors:  R Fulton; R Gallagher; D Crouch; J C Neil
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.

Authors:  C V Ngo; M Gee; N Akhtar; D Yu; O Volpert; R Auerbach; A Thomas-Tikhonenko
Journal:  Cell Growth Differ       Date:  2000-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.